EdgarLookup

Aardvark Therapeutics, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Financials Insiders
Insider Title Type Shares Price Value Date
Sun Nelson Chief Financial Officer Purchase 3,000 $14.40 $43,200 Dec 11, 2025
Lee Tien-Li Chief Executive Officer Purchase 7,000 $14.49 $101,430 Dec 11, 2025
Lee Tien-Li Chief Executive Officer Option Exercise 1,229 $4.24 $5,211 Oct 15, 2025
Jones Bryan Chief Operating Officer Option Exercise 1,250 $4.24 $5,300 Oct 15, 2025
Lee Tien-Li Chief Executive Officer Purchase 3,500 $9.94 $34,790 Sep 15, 2025
Lee Tien-Li Chief Executive Officer Purchase 5,000 $8.50 $42,500 Sep 11, 2025
Sun Nelson Chief Financial Officer Purchase 6,000 $8.07 $48,420 Sep 9, 2025
Lee Tien-Li Chief Executive Officer Option Exercise 17,209 $4.24 $72,966 Aug 28, 2025
Decheng Capital Global Life Sciences Fund IV, L.P. C 333,412 Feb 14, 2025
Chi Jeffrey C 133,364 Feb 14, 2025
Vickers Venture Fund VI Pte Ltd C 413,491 Feb 14, 2025
Lee Tien-Li Chief Executive Officer C 41,303 Feb 14, 2025
Sun Nelson Chief Financial Officer C 7,001 Feb 14, 2025
Chen Bihua C 800,189 Feb 14, 2025